Finerenone (Kerendia) is thought to work by inhibiting inflammation that can cause kidney damage, according to Drugs.com. The ...

SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney disease. However, there ...

Fears about the FDA imposing steep barriers to gene therapies for rare diseases appeared moot at an agency roundtable ...

An experimental medicine from Vera Therapeutics significantly reduced levels of toxic protein in the urine of patients with ...

Pfizer's CEO discussed the extensive due diligence the company has conducted on the 3SBio PD-1xVEGF deal. | Pfizer's CEO ...

Sibeprenlimab targets a protein called A proliferation-inducing ligand (APRIL), and the drug is designed to limit the ...

Unicycive Therapeutics shares lost nearly a third of their value on Tuesday after the clinical-stage biotechnology company said its bid to win U.S. Food and Drug Administration approval for its ...

More than one quarter of the medcines cleared by the FDA’s main review office since 2015 have been cancer drugs, a tally that ...

The FDA expanded the approval of the direct-acting antiviral (DAA) glecaprevir/pibrentasvir (Mavyret), making it the first ...

Using CRISPR to correct the mutations behind polycystic kidney disease could counter some of the damage the condition causes ...

Travere Therapeutics has turned music mogul, bringing together a singer-songwriter and Grammy-winning producer to create an ...

Phase 3 results revealed Monday led shares to surge and should yield an approval application in IgA nephropathy, a ...